We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
-7.13%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$216M
AUM Growth
-$131M
Cap. Flow
-$83.5M
Cap. Flow %
-38.69%
Top 10 Hldgs %
42.5%
Holding
85
New
16
Increased
22
Reduced
28
Closed
19

Top Buys

Rank Stock Value
1
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$4.88M
2
SAGE
Sage Therapeutics
SAGE
+$4.34M
3
TECX
Tectonic Therapeutic
TECX
+$4.04M
4
SDGR icon
Schrodinger
SDGR
+$3.02M
5
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
+$2.98M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$14.2M
2
BSX icon
Boston Scientific
BSX
+$12.4M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$9.42M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$8.04M
5
TFX icon
Teleflex
TFX
+$7M

Sector Composition

Rank Sector Weight
1 Healthcare 92.89%
2 Technology 1.17%
3 Industrials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITMR
26
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$3.13M 1.45%
265,650
+218,750
+466% +$2.98M
KOD icon
27
Kodiak Sciences
KOD
$2.72B
$3.11M 1.44%
65,218
-109,320
-63% -$6.56M
VCEL icon
28
Vericel Corp
VCEL
$2.29B
$3.03M 1.4%
330,296
-148,204
-31% -$2.22M
NTRA icon
29
Natera
NTRA
$45.5B
$2.54M 1.18%
85,133
-65,710
-44% -$2.2M
NUAN
30
DELISTED
Nuance Communications, Inc.
NUAN
$2.52M 1.17%
+150,056
New +$2.93M
IRMD icon
31
iRadimed
IRMD
$1.12B
$2.43M 1.13%
113,855
+20,355
+22% +$485K
MRNA icon
32
Moderna
MRNA
$25.4B
$2.25M 1.04%
+75,000
New +$1.73M
BBIO icon
33
BridgeBio Pharma
BBIO
$16.4B
$2.18M 1.01%
+75,215
New +$2.33M
SAGE
34
DELISTED
Sage Therapeutics
SAGE
$2.15M 1%
+75,000
New +$4.34M
SPNE
35
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$2.01M 0.93%
245,785
+133,345
+119% +$1.76M
MDGL icon
36
Madrigal Pharmaceuticals
MDGL
$12.4B
$2M 0.93%
+30,000
New +$2.5M
BCRX icon
37
BioCryst Pharmaceuticals
BCRX
$2.71B
$1.99M 0.92%
995,608
-145,604
-13% -$401K
KALA icon
38
KALA BIO
KALA
$17.1M
$1.98M 0.92%
+90
New +$1.44M
STXS icon
39
Stereotaxis
STXS
$139M
$1.97M 0.91%
653,693
+121,975
+23% +$504K
XENT
40
DELISTED
Intersect ENT, Inc
XENT
$1.97M 0.91%
165,923
+40,423
+32% +$896K
AUPH icon
41
Aurinia Pharmaceuticals
AUPH
$2.06B
$1.75M 0.81%
120,288
+20,288
+20% +$358K
TRIL
42
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.72M 0.8%
+425,000
New +$1.61M
MGTX icon
43
MeiraGTx Holdings
MGTX
$1.2B
$1.68M 0.78%
125,000
+42,706
+52% +$721K
ACRS icon
44
Aclaris Therapeutics
ACRS
$860M
$1.6M 0.74%
1,537,357
+1,312,357
+583% +$1.79M
NEPH icon
45
Nephros
NEPH
$47.4M
$1.58M 0.73%
251,366
+51,642
+26% +$438K
HAE icon
46
Haemonetics
HAE
$4.16B
$1.51M 0.7%
15,147
-45,103
-75% -$4.89M
INFU icon
47
InfuSystem Holdings
INFU
$244M
$1.45M 0.67%
170,483
+45,483
+36% +$411K
MSON
48
DELISTED
Misonix Inc
MSON
$1.41M 0.65%
150,000
-62,500
-29% -$948K
ATEC icon
49
Alphatec Holdings
ATEC
$1.49B
$1.3M 0.6%
376,599
-73,401
-16% -$422K
INSP icon
50
Inspire Medical Systems
INSP
$1.68B
$1.21M 0.56%
20,000
-4,750
-19% -$352K
1
2
3 4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Parkman Healthcare Partners held 85 positions worth $216M, down 38% from $346M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Parkman Healthcare Partners withdrew a net $83.5M in Q1 2020, closing 19 positions and reducing 28 holdings. Its most notable exit was Zimmer Biomet, an estimated $14.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Technology and Industrials.

Against the trend, Parkman Healthcare Partners opened a new position in Momenta Pharmaceuticals, Inc. worth $4.77M.

  • Parkman Healthcare Partners's largest Q1 2020 buy was Momenta Pharmaceuticals, Inc.: 175,453 shares worth $4.77M.
  • Parkman Healthcare Partners added most to Tectonic Therapeutic in Q1 2020, an estimated $4.04M increase.
  • Parkman Healthcare Partners's biggest Q1 2020 reduction was Seagen Inc. Common Stock, cutting an estimated $9.42M.
  • Parkman Healthcare Partners fully exited Zimmer Biomet in Q1 2020, selling an estimated $14.2M.
  • Parkman Healthcare Partners's ten largest holdings make up 42% of its $216M portfolio in Q1 2020.
  • Parkman Healthcare Partners opened 16 new positions and closed 19 in Q1 2020.
  • Parkman Healthcare Partners's portfolio value fell 38% quarter-over-quarter to $216M.

Based on Parkman Healthcare Partners's 13F filing for Q1 2020, filed 15 May 2020.